Related Experiment Video
Updated: May 23, 2025
10:37
Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
Published on: November 25, 2022
4.9K
New and future perspectives in Behçet's syndrome
Bercemhan Sulu1, Gulen Hatemi1,2
1Department of Internal Medicine, Division of Rheumatology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.
Archives of Rheumatology
|March 10, 2025
Summary
Recent advances in Behçet
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Background:
- Behçet's syndrome is a complex systemic vasculitis with varied clinical presentations.
- Optimal disease control and prevention of long-term complications remain significant challenges.
Purpose of the Study:
- To review recent advancements in Behçet's syndrome management.
- To highlight emerging therapies and future research directions.
Main Methods:
- Review of current literature on Behçet's syndrome treatments.
- Focus on novel therapeutic agents and their mechanisms of action.
Main Results:
- Apremilast shows promise for mucocutaneous manifestations (oral ulcers).
- Tocilizumab (IL-6 inhibitor) effective for ocular involvement, but requires caution in vascular Behçet's.
- Investigational therapies include IL-17, IL-12/23, and JAK inhibitors.
Conclusions:
- Emerging therapies offer new avenues for managing Behçet's syndrome.
- Future research should focus on novel targets, personalized treatment, and improved assessment tools for better patient outcomes.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
86
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
86
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:49Meiosis I
192.0K
Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
192.0K
01:17Chronic Bowel Disorders: Introduction
375
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
375